about
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationA high-throughput microfluidic approach for 1000-fold leukocyte reduction of platelet-rich plasmaMassive GI bleeding due to accidental ASA inhalation.Lower or higher doses for prophylactic platelet transfusions: results of a meta-analysis of randomized controlled trials.Platelet dose for prophylactic platelet transfusions.Correction of coagulopathy for percutaneous interventions.Absolute immature platelet count may predict imminent platelet recovery in thrombocytopenic children following chemotherapy.Platelet transfusions: trigger, dose, benefits, and risks.Host platelets and, in part, neutrophils mediate lung accumulation of transfused UVB-irradiated human platelets in a mouse model of acute lung injury.Antibodies against human platelet alloantigens and human leucocyte antigen class 1 in Saudi Arabian multiparous women and multi-transfused patients.The Effects of Ultraviolet Light and Riboflavin on Inactivation of Viruses and the Quality of Platelet Concentrates at Laboratory Scale.Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children.Guidelines for the transfusion of platelets.Recommendations for the transfusion of plasma and platelets.A general change of the platelet transfusion policy from apheresis platelet concentrates to pooled platelet concentrates is associated with a sharp increase in donor exposure and infection rates.Clinical effectiveness and comparative hospital costs of different platelet dose strategies.The effects of nanomaterials on blood coagulation in hemostasis and thrombosis.Bio-inspired nanomedicine strategies for artificial blood components.Identification of acceptable HLA mismatches in immunized patients using single-antigen-expressing cell lines.Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.Reducing costs in flow-cytometric counting of residual white blood cells in blood products: utilization of a single-platform bead-free flow-rate calibration method.In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers.
P2860
Q24186359-38C84CD8-B836-48E1-A126-49B705838DEAQ24186913-53208B15-EB93-452F-A5F2-450D70BD081FQ24187751-0CC0F595-8CC7-4B44-A2DE-D76E8A044C77Q30826060-4792F196-0C47-4A15-90F3-BB988C2BFEFDQ33158043-A72142E1-2D96-460D-8DA0-030C741ABF1FQ33374336-04C6DC2E-F213-44C3-9CA5-6922CE70CF62Q33392855-86D18F7A-67AC-4078-BC7F-5FCCBE1B8B06Q33401040-AB90D441-E8B3-4F91-B028-81D49137B8BFQ33405948-335E31A3-42B5-48C5-9625-E468519E9DB8Q33870639-A03F03AD-8849-4958-AD03-113DFFFFE980Q34427497-CF667DDC-B1E8-4392-B40F-03D802D2364EQ35681149-44284337-7D30-4F6B-87DC-EABE63AFCDE6Q35682144-1772E649-19A2-4AC2-B8D2-C2FB99054C65Q36237664-EF9E76AD-AF6A-472F-ACBF-E8509093B1C0Q36798554-BC3FAF71-4FDA-47AD-8496-920CD8DBD89DQ37209117-8A2F515A-FD7E-4816-8A16-ED9213B1F904Q37867952-5E84DBEE-BA5C-4A83-BCCB-E1F838BB474CQ38235211-78FAD9B5-05B7-445C-8DED-726FD49DA620Q39081782-8E32222F-3C71-4756-97A5-07947B2295CBQ39179984-4B271A8E-D854-403F-B36B-B22B68C34173Q40153806-CCB90801-0B74-46CF-95CD-E85059EC0B85Q47324534-0E518C87-BBE5-4419-AFC1-67BAF3599A68Q50549313-7837CC8B-4937-4D23-87C4-E33D6408DCB0Q51953927-00F15287-C61C-4724-B986-75D7CC1365B2
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Optimizing platelet transfusion therapy.
@ast
Optimizing platelet transfusion therapy.
@en
type
label
Optimizing platelet transfusion therapy.
@ast
Optimizing platelet transfusion therapy.
@en
prefLabel
Optimizing platelet transfusion therapy.
@ast
Optimizing platelet transfusion therapy.
@en
P1433
P1476
Optimizing platelet transfusion therapy.
@en
P2093
Joanna Mary Heal
Neil Blumberg
P304
P356
10.1016/S0268-960X(03)00057-2
P577
2004-09-01T00:00:00Z